Alberto C. Guardo

A Dendritic Cell–Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication

Felipe García, Núria Climent, Alberto C. Guardo et al. · Science Translational Medicine · 2013 · 216 citations

Life Sciences, Immunology, Infectious Diseases +16

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

Lorna Leal, Alberto C. Guardo, Sara Morón‐López et al. · AIDS · 2018 · 97 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

Felipe García, Juan Carlos López Bernaldo de Quirós, Carmen Gómez et al. · Vaccine · 2011 · 80 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Differential Biological Role of CD3 Chains Revealed by Human Immunodeficiencies

María J. Recio, Miguel A. Moreno‐Pelayo, Alberto C. Guardo et al. · The Journal of Immunology · 2007 · 75 citations · Full text

Life Sciences, Immunology, Molecular Genetics +14

The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens

Carmen Gómez, José Luis Nájera, Beatriz Perdiguero et al. · Journal of Virology · 2011 · 75 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17